Views

Our young people advisory group reflect on the importance of young people involvement's in HIV policy and what they hope to see in the future.

Dr Tristan Barber, Chair of the British HIV Association, shares his professional and personal reflections for LGBT+ History Month on the theme of science and innovation.

It’s time to get lenacapavir approved by NHS England and out to people who need it.

As NICE prepares a final decision on long-acting injectable PrEP cabotegravir, National AIDS Trust calls for its approval as a way to tackle inequalities and to end new HIV cases.

PIP is a lifeline for thousands of people living with HIV – it has to be protected.

Daniel Fluskey, our Director of Policy, Research and Influencing takes a look back over what has been achieved in 2024, and what we still need to do as we head towards 2030.

Oluwakemi Agunbiade, our Senior Research & Policy Officer, writes about how health inequalities faced by Black people with and at risk of HIV are not new – and that is the problem.

Chloe Orkin, the Professor of Infection and Inequities at the Queen Mary University of London, talks about her career working in HIV.

Oluwakemi Agunbiade, our Policy and Research Officer, writes how National AIDS Trust is proud to have collaborated with the NHS England team, alongside ViiV and many of the people who contributed to our original findings, on the development of an e-learning module: ‘Breaking barriers in HIV care’.